Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
11/2001
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/07/2001EP0764165B1 Preparation of stereochemically pure oximes with muscarinic activity
11/07/2001EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/06/2001US6313247 Cinchonan based chiral selectors for separation of stereoisomers
11/03/2001CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001WO2001081355A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs
10/2001
10/31/2001EP0784621B1 Quinidine conjugates and their use in immunoassays
10/25/2001WO2001025215A3 Method for selectively dissociating cyclic carboxylic acid anhydrides
10/18/2001WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
10/18/2001WO2001076571A2 Use of sabcomeline in the treatment of anxiety
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP0652871B1 Benzodiazepine derivatives
10/16/2001US6303626 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/03/2001CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/02/2001CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
09/2001
09/26/2001EP0799201B1 Process for the preparation of substituted 4-ethyl-piperidines
09/20/2001WO2001068599A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
09/20/2001US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
09/20/2001CA2402746A1 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
09/19/2001EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
09/19/2001EP1133480A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
09/19/2001EP0770077B1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
09/19/2001EP0500864B1 Antimuscarinic bronchodilators
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288228 Triazine angiogenesis inhibitors
09/11/2001US6288225 Substituted benzolactam compounds as substance P antagonists
09/07/2001WO2001064656A1 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/05/2001EP0632809B1 Quinuclidine derivatives as substance p antagonists
09/04/2001US6284771 Administering an heterocycle nitrogen compound
08/2001
08/30/2001WO2001062758A1 Pteridine compounds for the treatment of psoriasis
08/30/2001WO2001011968A3 Heterocyclic spiro compounds as pesticides
08/28/2001US6281233 Method of treating gastrointestinal motility disorders
08/28/2001US6281232 Azabicyclic ring-substituted thia- or oxadiazoles
08/28/2001US6281226 Pleuromutilin derivatives as antimicrobials
08/28/2001CA2101572C Benzoxazinones as inhibitors of hiv reverse transcriptase
08/23/2001WO2001060821A1 Novel biarylcarboxamides
08/23/2001CA2397233A1 Biarylcarboxamides
08/22/2001EP1125935A2 Quinidine conjugates and their use in immunoassays
08/22/2001EP1125922A1 Pyrrolidine compounds and medicinal utilization thereof
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/22/2001EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists
08/16/2001WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001WO2001058421A1 Cosmetic compositions based on thiosalicylic derivatives and novel thiosalicylic derivatives of quinolyl type
08/16/2001CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/15/2001CN1308251A Photographic element, compound and method containing azacyclo-substrated color former
08/14/2001US6274757 Neuromuscular relaxants
08/14/2001US6274734 Process for making pyrimidine derivatives
08/14/2001US6274623 Neuromuscular relaxants
08/14/2001US6274598 Methods for treating antibiotic-resistant infections
08/09/2001WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
08/09/2001CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
08/07/2001US6271229 Method of treating gastrointestinal motility disorders
08/01/2001EP1119354A1 Peripherally acting anti-pruritic opiates
08/01/2001EP0941228B1 PROCESS FOR PREPARING MeO-Peg-PROTECTED DIHYDROQUININE OR DIHYDROQUINIDINE DERIVATIVES, DIHYDROQUININE OR DIHYDROQUINIDINE DERIVATIVES AND THEIR USE
07/2001
07/31/2001US6268369 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
07/31/2001US6268308 Herbicidal S-substituted 1,2,4,6-thiatriazines
07/25/2001EP1118907A2 Photographic element containing nitrogen heterocycle substituted cyan coupler, compound and process
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/24/2001US6265419 Irritable bowel disorder
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/24/2001CA2171972C Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
07/19/2001WO2001004118A3 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands
07/18/2001CN1304392A Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
07/18/2001CN1068598C Resolution of 1-azabicyclo [2.2.2] octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl) phenyl]methyl]
07/17/2001US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
07/11/2001EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles
07/04/2001EP0850236B1 Piperazino derivatives as neurokinin antagonists
07/03/2001US6255320 Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
06/2001
06/28/2001WO2001046188A1 Optically active isomers of quinine and quinidine and their respective biological action
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/21/2001WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
06/21/2001CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
06/20/2001EP0714394B1 Antipsychotic method with thiadiazole and oxadiazole derivatives
06/20/2001CN1300289A Novel cephalotaxane derivatives and process for their preparation
06/19/2001US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
06/14/2001WO2001042213A1 Urea compounds having muscarinic receptor antagonist activity
06/14/2001WO2001042212A1 Carbamate derivatives having muscarinic receptor antagonist activity
06/13/2001EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
06/12/2001US6245761 Indolyl neuropeptide Y receptor antagonists
06/12/2001US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
06/10/2001CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/05/2001US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present
06/05/2001US6242443 1,2,4-benzothiadiazine derivatives, their preparation and use
05/2001
05/29/2001US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials
05/25/2001WO2001036417A1 New use and novel n-azabicyclo-amide derivatives
05/25/2001CA2389604A1 New use and novel n-azabicyclo-amide derivatives
05/23/2001EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists
05/23/2001EP0900218A4 Heterocyclic compounds
05/22/2001CA2031937C Isomers of 1-azabicyclo¬2.2.2|oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate
05/17/2001WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists
05/17/2001CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists
05/16/2001EP1098883A1 Process for preparing heterocyclic compounds
05/10/2001WO2001032264A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
05/10/2001WO2001032177A1 2-aza-bicyclo[2.2.2]octane nmda/nr2b antagonists
05/10/2001CA2389645A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
05/10/2001CA2389182A1 2-aza-bicyclo¬2.2.2|octane nmda/nr2b antagonists
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 58